Copley Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Buy
2,135
+35
+2% +$8.15K 0.31% 44
2025
Q4
$435K Sell
2,100
-2,294
-52% -$454K 0.27% 59
2025
Q3
$815K Sell
4,394
-131
-3% -$22.4K 0.56% 27
2025
Q2
$691K Sell
4,525
-151
-3% -$23.2K 0.51% 30
2025
Q1
$775K Buy
4,676
+356
+8% +$55.7K 0.59% 28
2024
Q4
$625K Buy
4,320
+146
+3% +$22.6K 0.48% 40
2024
Q3
$676K Buy
+4,174
New +$665K 0.61% 28

Other funds holding JNJ

Copley Financial Group's JNJ Position: Q1 2026 in Review

Copley Financial Group increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, buying an estimated $8.15K and bringing the position to 2,135 shares worth $522K. The position accounts for 0.31% of the portfolio, ranked #44.

Copley Financial Group first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. The position peaked at $815K in Q3 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Copley Financial Group held 2,135 shares of Johnson & Johnson worth $522K as of Q1 2026.
  • Copley Financial Group bought 35 Johnson & Johnson shares in Q1 2026, an estimated $8.15K.
  • Johnson & Johnson made up 0.31% of Copley Financial Group's portfolio in Q1 2026, its #44 holding.
  • Copley Financial Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • Copley Financial Group's Johnson & Johnson position peaked at $815K in Q3 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Copley Financial Group's 13F filing for Q1 2026, filed 15 May 2026.